Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04376502 · ClinicalTrials.gov registry record · NA
Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.
A NA study, sponsored by Baptist Health South Florida.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04376502 is a NA study that was terminated before completion, run by Baptist Health South Florida. The registered enrollment target is 12 participants.
The verdict
NCT04376502, a NA study, was terminated before completion, sponsored by Baptist Health South Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is an open label single arm phase 2 clinical trial in patients with metastatic solid malignancy of any histology who have previously experienced limited progression in at least 1 and up to 5 lesions while on immune checkpoint inhibitors monotherapy.
Interventions
- RADIATION Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-04-08 |
| Est. Completion | 2023-10-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04376502
The ClinicalTrials.gov registry entry for NCT04376502 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baptist Health South Florida, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiation Therapy is the first listed.
NCT04376502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04376502 about?
NCT04376502 is a clinical study titled "Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.". This is an open label single arm phase 2 clinical trial in patients with metastatic solid malignancy of any histology who have previously experienced limited progression in at least 1 and up to 5 lesions while on immune checkpoint inhibitors monotherapy.
What is the current status of trial NCT04376502?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2020-04-08. Estimated completion is 2023-10-04.
What interventions are being tested in trial NCT04376502?
The interventions under investigation include: Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT04376502?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.